GlassScriptPhysician profile
Lori J Williams
NPI 1881762540
$11,172.54
in general payments reported to CMS, 2019-2025
40 companies · $2,384 in 2025
The $2,384 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,083 · 2022: $2,158 · 2023: $1,774 · 2024: $2,773 · 2025: $2,384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,931.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,931.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,671.19 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,594.22 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $1,550.59 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $891.84 | 2021-2025 | Jardiance |
| Lilly USA, LLC | $685.95 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $465.92 | 2021-2025 | |
| Axsome Therapeutics, INC. | $421.28 | 2022-2025 | Auvelity |
| Amgen INC. | $372.17 | 2021-2025 | Evenity, Repatha, Repatha |
| Otsuka America Pharmaceutical, INC. | $308.68 | 2023-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Pfizer INC. | $280.85 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $277.16 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $262.58 | 2024-2025 | Voquezna |
| Glaxosmithkline, LLC. | $257.05 | 2021-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Merck Sharp & Dohme LLC | $223.25 | 2021-2023 | Belsomra, Verquvo, Steglatro |
| Exact Sciences Corporation | $201.60 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.